keyword
Keywords Myocardial infarction health u...

Myocardial infarction health utility

https://read.qxmd.com/read/38458582/association-of-serum-homocysteine-with-peripheral-arterial-disease-in-non-diabetic-patients-a-study-based-on-national-health-and-nutrition-examination-survey-database
#21
JOURNAL ARTICLE
Yi You, Naxin Zeng, Wengao Wu, Boyang Liu, Sheng Rong, Dong Xu
To investigate association of serum homocysteine (Hcy) levels with peripheral arterial disease (PAD) in non-diabetic patients based on data from National Health and Nutrition Examination Survey (NHANES). The study utilized data from three survey cycles (1999-2004) in NHANES database as the research dataset. Serum Hcy levels were considered as independent variable, while PAD was dependent variable. Weighted logistic regression and restricted cubic spline (RCS) methods were used to explore the relationship between Hcy level and PAD risk in non-diabetic patients...
March 6, 2024: American Journal of Cardiology
https://read.qxmd.com/read/38457553/construction-of-lncrna-mediated-cerna-network-for-investigating-the-immune-pathogenesis-of-myocardial-infarction
#22
JOURNAL ARTICLE
Dongmei Wei, Yuanting Meng, Hua Fan, Yang Sun, Rongtao Chen
BACKGROUND: Myocardial infarction (MI) is a cardiovascular disease that seriously threatens human health. However, an immune-related competitive endogenous RNA (ceRNA) network has not been reported in MI. METHODS: The GSE66360, GSE19339, GSE97320, GSE61741, and GSE168281 datasets were acquired from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) and differentially expressed miRNAs (DEmiRNAs) from MI patients and healthy controls were screened and an immune-related ceRNA network was constructed...
March 8, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38448901/a-cross-sectional-study-determining-prevalence-and-factors-associated-with-st-segment-elevation-myocardial-infarction-and-non-st-segment-elevation-myocardial-infarction-in-iran-results-from-fasa-registry-on-acute-myocardial-infarction-farmi
#23
JOURNAL ARTICLE
Mehdi Sharafi, Azizallah Dehghan, Ali Mouseli, Hossein Fatemian, Leila Jamali, Sima Afrashteh, Mahsa Rostami Chijan, Zahra Mastaneh, Abdoljabbar Zakeri, Abdulhakim Alkamel
BACKGROUND: Acute myocardial infarction is still a leading cause of death worldwide, accounting for roughly three million deaths yearly. This study aimed to investigate the prevalence and factors associated with ST-Segment Elevation Myocardial Infarction and Non-ST Segment Elevation Myocardial Infarction in Iran. METHODS: This cross-sectional study was conducted using the databases of the Fasa Registry on Acute Myocardial Infarction (FaRMI) and the Fasa Adult Cohort Study (FACS)...
March 6, 2024: BMC Public Health
https://read.qxmd.com/read/38438119/association-between-use-of-sodium-glucose-cotransporter-2-inhibitors-or-angiotensin-receptor-neprilysin-inhibitor-and-the-risk-of-atherosclerotic-cardiovascular-disease-with-coexisting-diabetes-and-heart-failure
#24
JOURNAL ARTICLE
Ya-Wen Lin, Chun-Hsiang Lin, Cheng-Li Lin, Che-Huei Lin, Ming-Hung Lin
PURPOSE: This study was to investigate the association between the use of Sodium-glucose Cotransporter-2 inhibitors (SGLT2i) or angiotensin receptor-neprilysin inhibitor (ARNI; ie, Sacubitril + valsartan, Product name ENTRESTO) and the risk of atherosclerotic cardiovascular disease (ASCVD) in patients with coexisting diabetes and heart failure. Specifically, the study compared outcomes between patients using SGLT2i or valsartan + sacubitril and those not using these medications...
2024: Journal of Cardiovascular Pharmacology and Therapeutics
https://read.qxmd.com/read/38436491/real-world-impact-of-blood-pressure-control-in-patients-with-apparent-treatment-resistant-or-difficult-to-control-hypertension-and-stages-3-and-4-chronic-kidney-disease
#25
JOURNAL ARTICLE
George Bakris, Cindy Chen, Alicia K Campbell, Veronica Ashton, Lloyd Haskell, Mukul Singhal
BACKGROUND: Chronic kidney disease (CKD) is a common comorbidity in patients with apparent treatment-resistant hypertension (aTRH). We assessed clinical outcomes, healthcare resource utilization events, and costs in patients with aTRH or difficult-to-control hypertension and stage 3-4 CKD with uncontrolled versus controlled blood pressure (BP). METHODS: This retrospective cohort study used linked IQVIA Ambulatory EMR-US and IQVIA PharMetrics® Plus claims databases...
March 4, 2024: American Journal of Hypertension
https://read.qxmd.com/read/38432948/real-world-clinical-profile-of-patients-prescribed-evolocumab-in-japan
#26
JOURNAL ARTICLE
Feng Sheng, Alex Y Wang, Kazumasa Miyawaki, Takahiro Tsuchiya, Nobuhiro Osada, Russell Miller, Ziyang Fu, Tomonori Okamura
BACKGROUND: Real-world utilization data for evolocumab, the first proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to be introduced in Japan in 2016, to date are limited. This study aimed to clarify the current real-world patient user profiles of evolocumab based on large-scale health claims data.Methods and Results: This retrospective database study examined patients from a health administrative database (MDV database) who initiated evolocumab between April 2016 (baseline) and November 2021...
March 1, 2024: Circulation Journal: Official Journal of the Japanese Circulation Society
https://read.qxmd.com/read/38431146/long-term-impact-of-mediterranean-diet-on-cardiovascular-disease-prevention-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#27
REVIEW
Sneha Annie Sebastian, Inderbir Padda, Gurpreet Johal
BACKGROUND: Dietary modification plays a pivotal role in the prevention of cardiovascular disease (CVD), with particular emphasis on the potential benefits associated with adopting a Mediterranean diet (MedDiet). Numerous observational studies have explored the impact of the MedDiet on CVD prevention, addressing both primary and secondary prevention. However, a substantial portion of the primary evidence comes from specific Randomized Controlled Trials (RCTs), such as the Lyon Diet Heart Study, the Indo-Mediterranean Diet Heart Study, the PREDIMED Study, and the recent CORDIOPREV Study...
March 1, 2024: Current Problems in Cardiology
https://read.qxmd.com/read/38408270/factors-influencing-the-indication-of-coronary-angiography-in-patients-presenting-with-chest-pain-unspecified-an-analysis-of-two-decades-1994-2014
#28
JOURNAL ARTICLE
Abel E Moreyra, Chirag Mehta, Nora M Cosgrove, Stavros Zinonos, Davit Sargsyan, Alex Gold, Mihir Trivedi, John B Kostis, Javier Cabrera, William J Kostis
Guidelines for cardiac catheterization in patients with non-specific chest pain (NSCP) provide significant room for provider discretion, which has resulted in variability in the utilization of invasive coronary angiograms (CAs) and a high rate of normal angiograms. The overutilization of CAs in patients with NSCP and discharged without a diagnosis of coronary artery disease is an important issue in medical care quality. As a result, we sought to identify patient demographic, socioeconomic, and geographic factors that influenced the performance of a CA in patients with NSCP who were discharged without a diagnosis of coronary artery disease...
February 20, 2024: International Journal for Quality in Health Care
https://read.qxmd.com/read/38391966/cellular-senescence-mitochondrial-dysfunction-and-their-link-to-cardiovascular-disease
#29
REVIEW
Maria Camacho-Encina, Laura K Booth, Rachael E Redgrave, Omowumi Folaranmi, Ioakim Spyridopoulos, Gavin D Richardson
Cardiovascular diseases (CVDs), a group of disorders affecting the heart or blood vessels, are the primary cause of death worldwide, with an immense impact on patient quality of life and disability. According to the World Health Organization, CVD takes an estimated 17.9 million lives each year, where more than four out of five CVD deaths are due to heart attacks and strokes. In the decades to come, an increased prevalence of age-related CVD, such as atherosclerosis, coronary artery stenosis, myocardial infarction (MI), valvular heart disease, and heart failure (HF) will contribute to an even greater health and economic burden as the global average life expectancy increases and consequently the world's population continues to age...
February 17, 2024: Cells
https://read.qxmd.com/read/38390493/acute-kidney-injury-prediction-model-utility-in-premature-myocardial-infarction
#30
JOURNAL ARTICLE
Fang Tao, Hongmei Yang, Wenguang Wang, Xile Bi, Yuhan Dai, Aihong Zhu, Pan Guo
The incidence of premature myocardial infarction (PMI) has been rising and acute kidney injury (AKI) occurring in PMI patients severely impacts prognosis. This study aimed to develop and validate a prediction model for AKI specific to PMI patients. The MIMIC-Ⅲ-CV and MIMIC-Ⅳ databases were utilized for model derivation of PMI patients. Single-center data served for external validation. There were 571 and 182 AKI patients in the training set (n = 937) and external validation set (n = 292) cohorts, respectively...
March 15, 2024: IScience
https://read.qxmd.com/read/38383606/health-care-utilization-and-the-associated-costs-attributable-to-cardiovascular-disease-in-ireland-a-cross-sectional-study
#31
JOURNAL ARTICLE
Danko Stamenic, Anthony P Fitzgerald, Katarzyna A Gajewska, Kate N O'Neill, Margaret Bermingham, Jodi Cronin, Brenda M Lynch, Sarah M O'Brien, Sheena M McHugh, Claire M Buckley, Paul M Kavanagh, Patricia M Kearney, Linda M O'Keeffe
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of mortality and disability globally. We examined healthcare service utilization and costs attributable to CVD in Ireland in the period before the introduction of a major healthcare reform in 2016. METHODS: Secondary analysis of data from 8 113 participants of the first wave of The Irish Longitudinal Study on Ageing. CVD was defined as having a self-reported doctor's diagnosis of myocardial infarction, angina, heart failure, stroke, atrial fibrillation or transient ischaemic attack...
February 21, 2024: European Heart Journal. Quality of Care & Clinical Outcomes
https://read.qxmd.com/read/38373064/temporal-trends-in-cardiac-rehabilitation-participation-and-its-core-components-a-nationwide-cohort-study-from-the-netherlands
#32
JOURNAL ARTICLE
Thijs Vonk, Martijn F H Maessen, Maria T E Hopman, Johan A Snoek, Vincent L Aengevaeren, Barry A Franklin, Thijs M H Eijsvogels, Esmee A Bakker
PURPOSE: Patient- and disease-specific data on cardiac rehabilitation (CR) participation and changes over time are limited. The objective of this study was to describe time trends in CR participation between 2013 and 2019 and provides insights into the utilization of CR components. METHODS: Patients with cardiovascular disease (CVD) with an indication for CR were enrolled between 2013 and 2019. Dutch health insurance claims data were used to identify CR participation and its components...
February 20, 2024: Journal of Cardiopulmonary Rehabilitation and Prevention
https://read.qxmd.com/read/38367623/sphingolipid-metabolism-controls-mammalian-heart-regeneration
#33
JOURNAL ARTICLE
Xiaoqian Ji, Zihao Chen, Qiyuan Wang, Bin Li, Yan Wei, Yun Li, Jianqing Lin, Weisheng Cheng, Yijie Guo, Shilin Wu, Longkun Mao, Yuzhou Xiang, Tian Lan, Shanshan Gu, Meng Wei, Joe Z Zhang, Lan Jiang, Jia Wang, Jin Xu, Nan Cao
Utilization of lipids as energy substrates after birth causes cardiomyocyte (CM) cell-cycle arrest and loss of regenerative capacity in mammalian hearts. Beyond energy provision, proper management of lipid composition is crucial for cellular and organismal health, but its role in heart regeneration remains unclear. Here, we demonstrate widespread sphingolipid metabolism remodeling in neonatal hearts after injury and find that SphK1 and SphK2, isoenzymes producing the same sphingolipid metabolite sphingosine-1-phosphate (S1P), differently regulate cardiac regeneration...
February 7, 2024: Cell Metabolism
https://read.qxmd.com/read/38354425/a-bibliometric-analysis-of-tenecteplase-research-utilizing-a-commonly-used-citation-index
#34
JOURNAL ARTICLE
Brendan Huang, Richard Libman, Ahmad Ballout, Gianluca DiUbaldi, Rohan Arora, Jeffrey M Katz
BACKGROUND AND PURPOSE: Tenecteplase is increasingly being used as a first-line treatment for acute ischemic stroke after several randomized studies demonstrated its safety and efficacy, resulting in a massive increase in the number of published studies on this topic. Our aim was to investigate the most impactful authors and relevant journals that have been instrumental in validating this treatment, in hopes of identifying objective research trends that may assist scientists, health organizations, and funding agencies to collaborate and plan future avenues of research...
February 8, 2024: Clinical Neurology and Neurosurgery
https://read.qxmd.com/read/38343794/sex-based-utilization-of-guideline-recommended-statin-therapy-and-cardiovascular-disease-outcomes-a-primary-prevention-healthcare-network-registry
#35
Agnes Koczo, Adipong Brickshawana, Jianhui Zhu, Floyd Thoma, Malamo Countouris, Kathryn Berlacher, Martha Gulati, Erin D Michos, Steven Reis, Suresh Mulukutla, Anum Saeed
BACKGROUND: In the US, women have similar cardiovascular death rates than men. Less is known about sex differences in statin use for primary prevention and associated atherosclerotic cardiovascular disease (ASCVD) outcomes. METHODS: Statin prescriptions using electronic health records were examined in patients without ASCVD (myocardial infarction (MI), revascularization or ischemic stroke) between 2013-2019. Guideline-directed statin intensity (GDSI) at index and follow-up visits were compared among sexes across ASCVD risk groups, defined by pooled-cohort equation...
January 23, 2024: medRxiv
https://read.qxmd.com/read/38322664/biomimetic-nanomaterials-in-myocardial-infarction-treatment-harnessing-bionic-strategies-for-advanced-therapeutics
#36
REVIEW
Tingting Yu, Qiaxin Xu, Xu Chen, Xiujiao Deng, Nenghua Chen, Man Teng Kou, Yanyu Huang, Jun Guo, Zeyu Xiao, Jinghao Wang
Myocardial infarction (MI) and its associated poor prognosis pose significant risks to human health. Nanomaterials hold great potential for the treatment of MI due to their targeted and controlled release properties, particularly biomimetic nanomaterials. The utilization of biomimetic strategies based on extracellular vesicles (EVs) and cell membranes will serve as the guiding principle for the development of nanomaterial therapy in the future. In this review, we present an overview of research progress on various exosomes derived from mesenchymal stem cells, cardiomyocytes, or induced pluripotent stem cells in the context of myocardial infarction (MI) therapy...
April 2024: Materials today. Bio
https://read.qxmd.com/read/38309464/the-dynamic-nature-of-the-socioeconomic-determinants-of-cardiovascular-health-a-narrative-review
#37
REVIEW
David A Alter, Peter C Austin, Aaron Rosenfeld
Despite decades of social epidemiologic research, health inequities remain pervasive and ubiquitous in Canada and elsewhere. One reason may be our use of socioeconomic measurement, which have often relied on single point-in-time exposures. To explore the extent to which researchers have incorporated dynamic socioeconomic measurement into cardiovascular health outcome evaluations, we performed a narrative review. We estimated the prevalence of socioeconomic longitudinal cardiovascular research studies that identified socioeconomic exposures at two or more points in time between the years of 2019 and 2023...
February 1, 2024: Canadian Journal of Cardiology
https://read.qxmd.com/read/38290442/correlation-between-intracoronary-vascular-ultrasound-indexes-in-patients-with-coronary-heart-disease
#38
JOURNAL ARTICLE
Pengxiang Zhang, Rui Wang, Aiai Zhang, Feixing Li, Xiaoning Li, Weiguang Chen, Huixian Li, Zhuoran Li, Fangjiang Li
BACKGROUND: Coronary atherosclerosis is a serious and progressive condition characterized by the accumulation of plaques, consisting of fat, cholesterol, and other substances, within the arteries that supply blood to the heart. These plaques can harden and narrow the arteries, leading to reduced blood flow to the heart muscle. OBJECTIVE: The primary objective of this study is to investigate the correlation between specific cardiovascular parameters and intracoronary vascular ultrasound indexes in patients diagnosed with coronary heart disease...
January 1, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38287280/analysis-of-the-correlation-between-serum-klotho-and-feno-a-cross-sectional-study-from-nhanes-2007-2012
#39
JOURNAL ARTICLE
Haiyan Mao, Zhenye Xie, Shanshan Huang, Xingkai Shen, Shaofeng Jin, Tong Lin, Zhouxin Yang
BACKGROUND: Klotho is an anti-aging protein that has multiple functions and may play a key role in the pathogenesis and progression of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD). Fractional Exhaled Nitric Oxide (FeNO) is a non-invasive and novel biomarker that has the advantages of being simple, fast and reproducible. It can effectively assess the degree of airway inflammation in diseases such as asthma and COPD. Despite these insights, the relationship between serum Klotho levels and FeNO has not been explored yet...
January 29, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38270954/cost-effectiveness-of-fractional-flow-reserve-guided-treatment-for-acute-myocardial-infarction-and-multivessel-disease-a-prespecified-analysis-of-the-frame-ami-randomized-clinical-trial
#40
JOURNAL ARTICLE
David Hong, Seung Hun Lee, Jin Lee, Hankil Lee, Doosup Shin, Hyun Kuk Kim, Keun Ho Park, Eun Ho Choo, Chan Joon Kim, Min Chul Kim, Young Joon Hong, Myung Ho Jeong, Sung Gyun Ahn, Joon-Hyung Doh, Sang Yeub Lee, Sang Don Park, Hyun-Jong Lee, Min Gyu Kang, Jin-Sin Koh, Yun-Kyeong Cho, Chang-Wook Nam, Ki Hong Choi, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Seung-Hyuk Choi, Hyeon-Cheol Gwon, Eliseo Guallar, Juhee Cho, Joo-Yong Hahn, Danbee Kang, Joo Myung Lee
IMPORTANCE: Complete revascularization by non-infarct-related artery (IRA) percutaneous coronary intervention (PCI) in patients with acute myocardial infarction is standard practice to improve patient prognosis. However, it is unclear whether a fractional flow reserve (FFR)-guided or angiography-guided treatment strategy for non-IRA PCI would be more cost-effective. OBJECTIVE: To evaluate the cost-effectiveness of FFR-guided compared with angiography-guided PCI in patients with acute myocardial infarction and multivessel disease...
January 2, 2024: JAMA Network Open
keyword
keyword
41651
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.